{"entity":{"type":"insider","cik":"0001932527","url":"/insider/0001932527","json_url":"/insider/0001932527.json","name":"Chambers Michael Andrew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":6,"first":"2022-08-22","last":"2024-08-20","span_basis":"filed_date"},"name_variants":[{"name":"Chambers Michael Andrew","source":"filing","n_filings":6,"first_seen":"2022-08-22","last_seen":"2024-08-20"}],"transactions":[{"id":3255537,"accession":"0000950170-24-098859","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-098859","line_url":"/filing/0000950170-24-098859","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001932527","owner_name":"Chambers Michael Andrew","owner_display_name":"Chambers Michael Andrew","owner_url":"/insider/0001932527","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":37038.0,"shares_display":"37,038","price_per_share":133.80118094929531,"price_display":"133.80","price_state":"stated","total_value":4955728.14,"total_display":"4,955,728.14","total_whole":"4,955,728","shares_owned_after":278386.0,"shares_owned_after_display":"278,386","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-20","scope":"insider","n_lines":3},{"id":8372998,"accession":"0001209191-23-045766","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-045766","line_url":"/filing/0001209191-23-045766","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001932527","owner_name":"Chambers Michael Andrew","owner_display_name":"Chambers Michael Andrew","owner_url":"/insider/0001932527","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9979.0,"shares_display":"9,979","price_per_share":109.47283395129773,"price_display":"109.47","price_state":"stated","total_value":1092429.41,"total_display":"1,092,429.41","total_whole":"1,092,429","shares_owned_after":242964.0,"shares_owned_after_display":"242,964","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-14","filed_date":"2023-08-15","scope":"insider","n_lines":2},{"id":8404774,"accession":"0001209191-23-045498","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-045498","line_url":"/filing/0001209191-23-045498#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001932527","owner_name":"Chambers Michael Andrew","owner_display_name":"Chambers Michael Andrew","owner_url":"/insider/0001932527","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23686.0,"shares_display":"23,686","price_per_share":108.05,"price_display":"108.05","price_state":"stated","total_value":2559272.3,"total_display":"2,559,272.30","total_whole":"2,559,272","shares_owned_after":237017.0,"shares_owned_after_display":"237,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-14","scope":"insider"},{"id":8334429,"accession":"0001209191-23-045366","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-045366","line_url":"/filing/0001209191-23-045366","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001932527","owner_name":"Chambers Michael Andrew","owner_display_name":"Chambers Michael Andrew","owner_url":"/insider/0001932527","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34867.0,"shares_display":"34,867","price_per_share":106.14813778070955,"price_display":"106.15","price_state":"stated","total_value":3701067.12,"total_display":"3,701,067.12","total_whole":"3,701,067","shares_owned_after":213331.0,"shares_owned_after_display":"213,331","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-10","filed_date":"2023-08-11","scope":"insider","n_lines":3},{"id":6753721,"accession":"0001209191-22-050002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-050002","line_url":"/filing/0001209191-22-050002","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001932527","owner_name":"Chambers Michael Andrew","owner_display_name":"Chambers Michael Andrew","owner_url":"/insider/0001932527","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":57100.0,"shares_display":"57,100","price_per_share":104.433,"price_display":"104.43","price_state":"stated","total_value":5963124.3,"total_display":"5,963,124.30","total_whole":"5,963,124","shares_owned_after":101928.0,"shares_owned_after_display":"101,928","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-14","filed_date":"2022-09-15","scope":"insider","n_lines":3},{"id":6699815,"accession":"0001209191-22-046973","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-046973","line_url":"/filing/0001209191-22-046973","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001932527","owner_name":"Chambers Michael Andrew","owner_display_name":"Chambers Michael Andrew","owner_url":"/insider/0001932527","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":46170.0,"shares_display":"46,170","price_per_share":108.27875243664717,"price_display":"108.28","price_state":"stated","total_value":4999230.0,"total_display":"4,999,230.00","total_whole":"4,999,230","shares_owned_after":45018.0,"shares_owned_after_display":"45,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-19","filed_date":"2022-08-22","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":14,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000873303","name":"Sarepta Therapeutics, Inc.","url":"/issuer/0000873303","role":"Director","n_filings":6,"first_seen":"2022-08-22","last_seen":"2024-08-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001932527","retrieved_at":"2026-08-24T07:24:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}